G1 Therapeutics, Inc. (GTHX) has 20 known insider and institutional holders on record. The largest holder is Thorp Clay with 3,237,711 shares. Other notable holders include MedImmune Ventures, Inc. and Bailey John E. (Jack) Jr..
GTHX Insider Ownership
Top Holder
Thorp Clay
3,237,711 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Thorp Clay |
10 Percent Owner |
3,237,711 |
2018-06-01 |
|
| 2 |
Medimmune Ventures, Inc. |
10 Percent Owner |
2,950,630 |
2017-12-18 |
|
| 3 |
Bailey John E. (jack) Jr. |
President and CEO |
549,674 |
2024-07-08 |
|
| 4 |
Avagliano Mark |
Chief Business Officer |
242,045 |
2024-07-08 |
|
| 5 |
Umstead John W. V |
Chief Financial Officer |
187,718 |
2024-07-08 |
|
| 6 |
Malik Rajesh |
Chief Medical Officer |
159,312 |
2024-07-08 |
|
| 7 |
Thomas Monica R. |
Chief Legal & People Officer |
144,825 |
2024-07-03 |
|
| 8 |
Murdock Terry L |
Chief Operating Officer |
128,012 |
2024-07-08 |
|
| 9 |
Perry Andrew |
Chief Commercial Officer |
112,614 |
2024-07-08 |
|
| 10 |
Umstead John V. |
Chief Financial Officer |
93,886 |
2023-05-12 |
|
| 11 |
Phillips Barclay A |
SVP & Chief Financial Officer |
60,000 |
2019-01-02 |
|
| 12 |
Velleca Mark A. |
Director |
57,286 |
2022-10-20 |
|
| 13 |
Moses Jennifer K. |
CFO |
44,600 |
2023-01-05 |
|
| 14 |
Hanson James S. |
General Counsel |
35,700 |
2023-01-05 |
|
| 15 |
Deese Willie A |
Director |
30,000 |
2022-06-24 |
|
| 16 |
Muir Glenn P |
Director |
30,000 |
2024-06-14 |
|
| 17 |
Nicholson Garry A |
Director |
30,000 |
2024-06-14 |
|
| 18 |
Secor Alicia |
Director |
30,000 |
2024-06-14 |
|
| 19 |
Demaree John |
Chief Commercial Officer |
30,000 |
2020-02-07 |
|
| 20 |
Flowers Cynthia Louise |
Director |
30,000 |
2024-06-14 |
|
No ownership data available for GTHX.
